Use of prestudy heparin did not influence the efficacy and safety of rivaroxaban in patients treated for symptomatic venous thromboembolism in the EINSTEIN DVT and EINSTEIN PE studies - Prandoni, P; Prins, M H; Cohen, A T (Acad Emerg Med, 2015)
, et al.